tradingkey.logo
tradingkey.logo
Search

Ekso Bionics Holdings Inc

EKSO
Add to Watchlist
11.800USD
0.0000.00%
Market hours ETQuotes delayed by 15 min
3.20BMarket Cap
LossP/E TTM

More Details of Ekso Bionics Holdings Inc Company

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Ekso Bionics Holdings Inc Info

Ticker SymbolEKSO
Company nameEkso Bionics Holdings Inc
IPO dateApr 10, 2013
CEODavis (Scott G)
Number of employees61
Security typeOrdinary Share
Fiscal year-endApr 10
Address101 Glacier Point
CitySAN RAFAEL
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94901
Phone15109841761
Websitehttps://eksobionics.com/
Ticker SymbolEKSO
IPO dateApr 10, 2013
CEODavis (Scott G)

Company Executives of Ekso Bionics Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
67.10K
+59.61%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
30.45K
+17.12%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
25.27K
+26.45%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
5.21K
-201.96%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
67.10K
+59.61%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
30.45K
+17.12%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
25.27K
+26.45%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
5.21K
-201.96%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Ekso Bionics Holdings Inc?

The top five shareholders of Ekso Bionics Holdings Inc are: Mr. Jerome Wong

How many institutions hold shares of Ekso Bionics Holdings Inc (EKSO)?

As of 2026Q1, 66 institutions hold shares of Ekso Bionics Holdings Inc, with a combined market value of approximately 972.39K, accounting for 3.28% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 491581.00.